Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study

ConclusionRecruitment to a KD trial for patients with GBM is possible. A six-week intervention period is proposed for a phase III trial. The role of caregivers should not be underestimated. Future trials should optimize and adequately support the decision-making of patients.

http://link.springer.com/10.1007/s11060-020-03417-8

Source: Journal of Neuro-Oncology - February 7, 2020 Category: Cancer & Oncology Source Type: research